ArticleJournal of thrombosis and thrombolysis2017
Disproportional increase of pulmonary embolism in young females in Germany: trends from 2005 to 2014.
Article in Journal of thrombosis and thrombolysis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
- Bioinformatics-based study to detect chemical compounds that show potential as treatments for pulmonary thromboembolism.International journal of molecular medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We analysed the number of pulmonary embolism (PE) in young females aged 10-39 years in the period from 2005 to 2014 in Germany to see any trends that possibly may reflect some influences of newer oral contraceptives. Detailed lists of all hospitalized cases with the principal diagnosis PE coded as I26 in the years 2005-2014 were provided by the Federal Statistical Office. In males, the absolute number of all hospitalized cases with the principal diagnosis PE increased from 16,066 in 2005 to 25,364 in 2014 (rate +57.8%) and in females from 21,548 to 29,433 (rate +36.5%). The annual differences in PE between males and females decreased from 5482 to 4069 (-26%) in this period. In the age group of 10-39 years the absolute number of all hospitalized male cases increased from 1023 in 2005 to 1276 in 2014 (+24.7%) and in females from 1341 to 1949 (rate +45.3%). Thus in contrast to the overall trend the annual difference in PE rose gradually by 112% (from 318 to 673) from 2005 to 2014. Our ecologic nationwide analysis of hospitalization rates for PE shows that the annual differences between males and females cases hospitalized with the principal diagnosis PE in general decreased, but increased in the age group of 10-39 years in the last decade.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.